Pharmacokinetics and elimination of quetiapine, venlafaxine, and trazodone during pregnancy and postpartum

J Clin Psychopharmacol. 2007 Dec;27(6):720-2. doi: 10.1097/JCP.0b013e31815a57d8.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adolescent
  • Antipsychotic Agents / blood
  • Antipsychotic Agents / pharmacokinetics
  • Antipsychotic Agents / therapeutic use
  • Bipolar Disorder / complications
  • Bipolar Disorder / drug therapy
  • Bipolar Disorder / metabolism
  • Cyclohexanols / blood
  • Cyclohexanols / pharmacokinetics*
  • Cyclohexanols / therapeutic use
  • Dibenzothiazepines / blood
  • Dibenzothiazepines / pharmacokinetics*
  • Dibenzothiazepines / therapeutic use
  • Female
  • Humans
  • Postpartum Period / metabolism
  • Pregnancy
  • Pregnancy Outcome
  • Pregnancy Trimesters / metabolism
  • Quetiapine Fumarate
  • Sleep Wake Disorders / complications
  • Sleep Wake Disorders / drug therapy
  • Sleep Wake Disorders / metabolism
  • Trazodone / blood
  • Trazodone / pharmacokinetics*
  • Trazodone / therapeutic use
  • Venlafaxine Hydrochloride

Substances

  • Antipsychotic Agents
  • Cyclohexanols
  • Dibenzothiazepines
  • Quetiapine Fumarate
  • Venlafaxine Hydrochloride
  • Trazodone